New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Persons living with HIV (PLWH) in sub-Saharan Africa (SSA), lymphadenopathy often portends one of a number of life-threatening diseases including tuberculosis, lymphoma, and multicentric Castleman disease (MCD). Overcoming these delays and missed diagnoses requires new approaches to identify lymphoma and MCD.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 1 rok i masa ciała co najmniej 10 kg
- •Zakażenie wirusem HIV
- •Powiększone węzły chłonne o niejasnej przyczynie, z co najmniej jednym węzłem ≥2 cm, możliwym do pobrania próbki
- •Osoba dorosła (18+) może sama wyrazić zgodę, nastolatek (15-17 lat) i opiekun muszą wyrazić zgodę, dziecko (7-14 lat) i opiekun muszą wyrazić zgodę, dziecko poniżej 7 lat wymaga zgody opiekuna
✗ Disqualifies
- •Niemożność lub brak chęci do uczestnictwa w badaniu
- •Rak w ciągu ostatnich 5 lat (z wyjątkiem mięsaka Kaposiego, które jest dozwolone)
Simplified criteria — AI translation
Trial details
- Minimum age
- 1 Year
- Last updated (source)
- August 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Lighthouse Trust HIV Centers of Excellence
Lilongwe, Malawi
Trial contact
Matthew Painschab, MD
Yuri Fedoriw, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.